+ND Capital — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Orca Bioorcabio.com in 𝕏Nov 2019

Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome.

BiotechDigital HealthHealthtechMedical DevicesCalifornia, US

Ivan Dimov(Founder)in Nathaniel Fernhoff(Founder)inJeroen Bekaert, PhD(Co-founder and President)Nate Fernhoff, PhD(Co-founder and Chief Executive Officer)inBob Lowsky(Founder)Everett Meyer(Founder)

Co-investors8VC DCVC (Data Collective)Dream Variation Ventures Felicis Ventures Lightspeed Venture Partners Seraph Group +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.